Mild Clinical Course of COVID-19 Infection in Chronic Myeloid Leukemia (CML) Patients Receiving Tyrosine Kinase Inhibitors (TKIs) without Interruption
Mediterr J Hematol Infect Dis
.
2021 Mar 1;13(1):e2021022.
doi: 10.4084/MJHID.2021.022.
eCollection 2021.
Authors
Judit Demeter
1
,
Julia Weisinger
1
,
Zsolt Nagy
1
Affiliation
1
Semmelweis University Department of Internal Medicine and Oncology, Division of Hematology; Budapest, Hungary.
PMID:
33747403
PMCID:
PMC7938919
DOI:
10.4084/MJHID.2021.022
No abstract available
Keywords:
25-OH vitamin D; ABL; CML; COVID-19; SARS-CoV-2; TKI.